Home › Nephrotic Syndrome › Pennsylvania › Philadelphia
Nephrotic Syndrome clinical trials in Philadelphia, PA
3 studies for Nephrotic Syndrome are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Belimumab With Rituximab for Primary Membranous Nephropathy
RecruitingPhase 2
- University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division, Philadelphia
Nephrotic Syndrome Study Network
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
NEPTUNE Match Study
Recruiting
- Hospital of the University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
Nephrotic Syndrome trials in other cities
- San Francisco, CA4 studies
- Ann Arbor, MI4 studies
- Washington, DC3 studies
- Durham, NC3 studies
- Spokane, WA3 studies
- Cleveland, OH3 studies
- Baltimore, MD3 studies
- New York City, NY3 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.